A closer look at our authors.

Industry experience informs our questions. Published evidence supports our conclusions.

OC

Founding Editor

Owen Calder

Owen Calder approaches GLP-1 coverage through drug-development and healthcare-finance experience. He explains the evidence behind treatments and the practical differences between prescribing services, medication access and ongoing costs.

Read the profile
CR

Consumer Editor

Callum Reed

Callum Reed writes about the decisions behind a treatment purchase: access, ongoing charges and the care relationship. His perspective draws on healthcare investment banking and more than a decade building pharmaceutical companies.

Read the profile
Affiliate partner

Before you go

Explore this option
Continue to your original choiceWe may earn a commission if you choose our partner. These services may differ in products, fees and clinical access.